Cargando…

High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma

BACKGROUND: The purpose of this study was to explore the reason for guanine nucleotide binding‐protein gamma subunit‐4 (GNG4) overexpression and the relationship between GNG4 overexpression and the poor prognosis of lung adenocarcinoma (LUAD) patients. METHODS: The genes and phenotypes related to GN...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Bodong, Zhu, Wenbo, Yuan, Shuai, Wang, Yifei, Zhang, Qing, Zheng, Hong, Zhu, Lei, Xu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807281/ https://www.ncbi.nlm.nih.gov/pubmed/34951127 http://dx.doi.org/10.1111/1759-7714.14265

Ejemplares similares

High expression of PSMC2 promotes gallbladder cancer through regulation of GNG4 and predicts poor prognosis
por: Zhu, Dawei, et al.
Publicado: (2021)

GNG4, as a potential predictor of prognosis, is correlated with immune infiltrates in colon adenocarcinoma
por: Wang, Juan, et al.
Publicado: (2023)

Expression of NMU, PPBP and GNG4 in colon cancer and their influences on prognosis
por: Chen, Danyu, et al.
Publicado: (2022)

GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
por: Zhang, Wang, et al.
Publicado: (2021)

Overexpression of ANLN in lung adenocarcinoma is associated with metastasis
por: Xu, Jie, et al.
Publicado: (2019)

GNG4 Promotes Tumor Progression in Colorectal Cancer
por: Liang, Liang, et al.
Publicado: (2021)

High GNG4 predicts adverse prognosis for osteosarcoma: Bioinformatics prediction and experimental verification
por: Jiang, Xiaohong, et al.
Publicado: (2023)

High expression of prolyl 4-hydroxylase subunit alpha-2 in lung adenocarcinoma indicates poor prognosis
por: Lu, Xiao-Hong, et al.
Publicado: (2022)

High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma
por: Zhu, Yufei, et al.
Publicado: (2022)

Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates
por: Wei, Qin, et al.
Publicado: (2022)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

High expression of interleukin-enhancer binding factor 3 predicts poor prognosis in patients with lung adenocarcinoma
por: Xu, Zhangyan, et al.
Publicado: (2020)

Low expression of tRF‐Pro‐CGG predicts poor prognosis in pancreatic ductal adenocarcinoma
por: Li, Jun, et al.
Publicado: (2021)

GNG5 is an unfavourable independent prognostic indicator of gliomas
por: Yang, Biao, et al.
Publicado: (2020)

Loss of IL-34 Expression Indicates Poor Prognosis in Patients With Lung Adenocarcinoma
por: Wang, Zhendong, et al.
Publicado: (2021)

DDIT4 overexpression associates with poor prognosis in lung adenocarcinoma
por: Song, Li, et al.
Publicado: (2021)

GNG12 regulates PD‐L1 expression by activating NF‐κB signaling in pancreatic ductal adenocarcinoma
por: Li, Juan, et al.
Publicado: (2020)

Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma
por: Cai, Jinlian, et al.
Publicado: (2020)

High expression of monocarboxylate transporter 4 predicts poor prognosis in patients with lung adenocarcinoma
por: Ruan, Yushu, et al.
Publicado: (2017)

Expression of CC chemokine receptor 9 predicts poor prognosis in patients with lung adenocarcinoma
por: Zhong, Yonglong, et al.
Publicado: (2015)

Noncoding RNA-Mediated High Expression of PFKFB3 Correlates with Poor Prognosis and Tumor Immune Infiltration of Lung Adenocarcinoma
por: Gu, Xue, et al.
Publicado: (2023)

GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
por: Liu, Runze, et al.
Publicado: (2022)

Poor Prognosis of Gastric Adenocarcinoma with Decreased Expression of AHRR
por: Li, Yuan-fang, et al.
Publicado: (2012)

GNG7 and ADCY1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinoma through bioinformatic-based analyses
por: Zhang, Youfu, et al.
Publicado: (2021)

Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma
por: Yuan, Jinghong, et al.
Publicado: (2021)

CIP4 Promotes Lung Adenocarcinoma Metastasis and Is Associated with Poor Prognosis
por: Truesdell, P, et al.
Publicado: (2014)

The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma
por: Chen, Aifeng, et al.
Publicado: (2021)

High expression of DARS2 indicates poor prognosis in lung adenocarcinoma
por: Jiang, Yingfeng, et al.
Publicado: (2022)

High SERPINH1 expression predicts poor prognosis in lung adenocarcinoma
por: Zhang, Hailing, et al.
Publicado: (2022)

High Expression of PSRC1 Predicts Poor Prognosis in Lung Adenocarcinoma
por: Han, Rui, et al.
Publicado: (2023)

Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma
por: Niu, Cong, et al.
Publicado: (2022)

Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2020)

Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma
por: Song, Ying-Hua, et al.
Publicado: (2018)

Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma
por: Li, Mei-Xiang, et al.
Publicado: (2021)

High DSCC1 Level Predicts Poor Prognosis of Lung Adenocarcinoma
por: Chang, Sisi, et al.
Publicado: (2021)

High levels of serum glypican‐1 indicate poor prognosis in pancreatic ductal adenocarcinoma
por: Zhou, Cong‐ya, et al.
Publicado: (2018)

SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas
por: Xiao, Gang, et al.
Publicado: (2023)

Reduced Expression of PTPRD Correlates with Poor Prognosis in Gastric Adenocarcinoma
por: Wang, Dandan, et al.
Publicado: (2014)

High expression of 14-3-3ơ indicates poor prognosis and progression of lung adenocarcinoma
por: Feng, Junfei, et al.
Publicado: (2022)

Low expression of IL6R predicts poor prognosis for lung adenocarcinoma
por: Sun, Gaofeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5bi83p6dgi5qt8kuocsdf30co4